20
total announcements
539678.BO · 15 min delayed
Quick Heal Technologies Ltd
Quick Heal Technologies Ltd has allotted 9,746 equity shares under its ESOP Scheme 2021, with the shares to be credited to the permanent ISIN upon receipt of final trading approval.
Quick Heal Technologies Ltd
Quick Heal Technologies Ltd has appointed Mr. Amit Chaudhary as Vice President - Product Management with immediate effect, as recommended by the Nomination and Remuneration Committee.
Quick Heal Technologies Ltd
Quick Heal Technologies Ltd has published a newspaper advertisement announcing the completion of dispatch of its Integrated Annual Report and notice of the 31st Annual General Meeting to be held on September 23, 2026.
Quick Heal Technologies Ltd
Quick Heal Technologies Ltd has dispatched letters to shareholders with unregistered email addresses, providing a web-link to the Integrated Annual Report for FY 2025-26. The company has also announced its 31st Annual General Meeting (AGM) on September 23, 2026, through video conferencing.
Quick Heal Technologies Ltd
Quick Heal Technologies Ltd has announced the Integrated Annual Report for FY 2025-26, which includes the Notice convening the 31st Annual General Meeting (AGM) to be held on September 23, 2026, through Video Conferencing (VC) / Other Audio Visual Means (OAVM). The report is available on the company's website.
Quick Heal Technologies Ltd
Quick Heal Technologies Ltd has announced the notice of its 31st Annual General Meeting (AGM) to be held on September 23, 2026, through video conference. The meeting will consider the adoption of financial statements for the year 2025-26, appointment of a director, and re-appointment of a non-executive independent director.
Quick Heal Technologies Ltd
Quick Heal Technologies Ltd has announced the publication of a newspaper advertisement regarding the 31st Annual General Meeting (AGM) of the company, to be held on September 23, 2026, through video conferencing.
Quick Heal Technologies Ltd
Quick Heal Technologies Ltd has announced the 31st Annual General Meeting (AGM) to be held on September 23, 2026, through video conferencing. The meeting will transact the business set forth in the Notice of AGM through electronic voting. Remote e-voting will commence on September 19, 2026, and conclude on September 22, 2026.
Quick Heal Technologies Ltd
Quick Heal Technologies Ltd has granted 1,02,000 employee stock options under ESOP Scheme 2021, with an exercise price of ₹ 76 per share, a 50% discount of the NSE closing share price on August 10, 2026. The options are exercisable within a maximum period of 3 years from the date of vesting.
Quick Heal Technologies Ltd
Quick Heal Technologies Ltd has appointed Mr. Rajiv Sreekantan as Senior Vice President - Enterprise Sales, effective August 11, 2026.
Quick Heal Technologies Ltd
Quick Heal Technologies Ltd has announced the resignation of Mr. Samuel Sathyajith as Senior Vice President - Enterprise Sales, effective on or before September 4, 2026, to pursue his next professional journey.
Quick Heal Technologies Ltd
Quick Heal Technologies Ltd has announced the resignation of Dr. Lalit Mohan Sanagavarapu, Chief Product Officer, due to personal reasons, effective August 7, 2026.
Quick Heal Technologies Ltd
Quick Heal Technologies Ltd has published a newspaper advertisement regarding the outcome of its board meeting, as per the company's compliance with Regulation 30 of the Listing Obligations and Disclosure Requirements (LODR) of the Securities and Exchange Board of India (SEBI).
Quick Heal Technologies Ltd
Quick Heal Technologies Limited announced its unaudited financial results for the quarter ended June 30, 2026, with revenue of ₹45.0 Cr, EBITDA of ₹(17.6) Cr, and PAT of ₹(5.3) Cr.
Quick Heal Technologies Ltd
Quick Heal Technologies Ltd has granted 1,17,000 employee stock options under the ESOP Scheme 2021, with an exercise price of ₹ 79 per share. The options are exercisable within a maximum period of 3 years from the date of vesting. The grant is in accordance with the SEBI (Share Based Employee Benefits and Sweat Equity) Regulations, 2021.
Quick Heal Technologies Ltd
Quick Heal Technologies Ltd has proposed the re-appointment of Mr. Richard Stiennon as Non-Executive Independent Director for a second term of 5 consecutive years, subject to shareholder approval at the upcoming Annual General Meeting.
Quick Heal Technologies Ltd
Quick Heal Technologies Ltd has announced its unaudited financial results for the quarter ended June 30, 2026, with revenue of ₹45.0 Cr, EBITDA of ₹-17.6 Cr, and PAT of ₹-5.3 Cr. The company has also announced the re-appointment of Mr. Richard Stiennon as Non-Executive Independent Director for a second term of 5 consecutive years.
Quick Heal Technologies Ltd
Quick Heal Technologies Ltd announced its unaudited financial results for Q1 FY27, with revenue at ₹45.0 Cr, EBITDA at ₹-17.6 Cr, and PAT at ₹-5.3 Cr. The company also announced the re-appointment of Mr. Richard Stiennon as Non-Executive Independent Director for a second term of 5 years. The company's registered office has been shifted within the same city limit, and the books of accounts have been kept at the corporate office.
Quick Heal Technologies Ltd
Quick Heal Technologies Ltd has announced the allotment of 5332 ESOPs under the ESOP Scheme 2021, with shares to be credited to permanent ISIN upon final trading approval.
Quick Heal Technologies Ltd
Quick Heal Technologies Ltd has scheduled a board meeting on July 30, 2026, to consider and approve the un-audited financial results for the quarter ended June 30, 2026.